Linda.Bunschoten

About Linda Bunschoten - Chief Marketing Officer

Linda has 25+ years of experience uncovering pain points and strategizing with companies in the healthcare industry in order to secure and retain more clients. Her chief thinking responsibilities include translating insight into strategy and ensure that all MarCom and Product Management activities contribute to our overall customer experience and meet our industry’s quality expectations.
Mar 2023

Synergy of QbD, RBM, and RBQM in Trials

By |2024-06-14T17:44:33+02:00March 20, 2023|Blog, News|Comments Off on Synergy of QbD, RBM, and RBQM in Trials

Clinical trials require a comprehensive approach to ensure quality and efficiency. Quality by Design, Risk-Based Monitoring, and Risk-Based Quality Management work together to achieve these goals, focusing on building quality into the trial process, targeting monitoring activities, and continuously improving trial quality.

Mar 2023

Why the Industry Finds It Easier to Embrace Key Risk Indicators than Quality Tolerance Limits

By |2023-03-14T12:51:19+02:00March 14, 2023|Blog, News|Comments Off on Why the Industry Finds It Easier to Embrace Key Risk Indicators than Quality Tolerance Limits

This opinion piece by Keith Dorricott, MBB, addresses the challenges faced by the clinical trial industry in implementing QTLs and KRIs as required by ICH E6(R2). The article explores why KRIs have been easier to adopt than QTLs and wonders if the specific guidance provided by ICH E6(R2) is partly responsible.

Mar 2023

eyesON | Clinical Trials Global & Regional Insights Visualized

By |2023-06-21T17:35:41+02:00March 7, 2023|Interactive Data Visualizations, News|Comments Off on eyesON | Clinical Trials Global & Regional Insights Visualized

Explore clinical trial and enrollment activity across countries with ease. Our new eyesON application visualizes data from ClinicalTrials.gov, helping you gain a deeper understanding.

Mar 2023

What’s the Difference Between RBQM and QRM in Clinical Trials?

By |2024-06-14T18:09:56+02:00March 6, 2023|Blog, News|Comments Off on What’s the Difference Between RBQM and QRM in Clinical Trials?

In clinical trials, managing risks that could impact data quality is crucial for ensuring patient safety, data integrity, and regulatory compliance. While Risk-Based Quality Management (RBQM) and Quality Risk Management (QRM) are both approaches designed to manage risks, the two have essential differences.

Mar 2023

Cyntegrity and PwC Join Forces to Offer Innovative Solutions

By |2023-03-01T14:39:37+02:00March 1, 2023|News|Comments Off on Cyntegrity and PwC Join Forces to Offer Innovative Solutions

You won't want to miss our latest press release announcing the cooperation between Cyntegrity and PwC! The collaboration brings together Cyntegrity's cutting-edge technology solutions with PwC's expertise in professional services, data integration, and M&A activities.

Feb 2023

Cyntegrity Passes SOC 2 Type 2 Examination: Ensuring Top-Level Data Security

By |2023-03-02T15:40:13+02:00February 24, 2023|News|Comments Off on Cyntegrity Passes SOC 2 Type 2 Examination: Ensuring Top-Level Data Security

We're thrilled to announce that we've passed our SOC 2 Type 2 examination, which confirms our effective controls over confidentiality, privacy, and processing of online cloud platforms. SOC 2 compliance demonstrates our high level of information security and responsible handling of sensitive information.

Feb 2023

Choose Cyntegrity as Your Premier RBQM Software Provider

By |2023-03-14T22:03:46+02:00February 14, 2023|News, RBQM Product Updates|Comments Off on Choose Cyntegrity as Your Premier RBQM Software Provider

Looking for a comprehensive RBQM software solution for your clinical trials? Look no further than Cyntegrity, your premier RBQM software vendor. Our suite of RBQM tools is designed to help you proactively manage risk, enhance data privacy and security, and improve the quality and efficiency of your clinical trials. With our user-friendly tools, real-time monitoring and reporting, and dedicated customer support, Cyntegrity is the ultimate choice for all your RBQM software needs. And with the Cyntegrity MyRBQM Academy, you can enhance your RBQM expertise and take your clinical trials to the next level. Choose Cyntegrity as your premier RBQM software provider and transform your clinical trials today.

Feb 2023

Reflections on ICH E6(R3): Insights from SCOPE Summit 2023

By |2024-09-11T16:56:32+02:00February 13, 2023|Blog, Good Clinical Practice, News|Comments Off on Reflections on ICH E6(R3): Insights from SCOPE Summit 2023

Exciting news on ICH GCP E6(R3) is here! Our CEO, Artem Andrianov, returned from the SCOPE Summit with updates on the updated guideline. ICH E6(R3) will incorporate technology advancements while prioritizing participant protection and reliable evidence. Don't miss Artem's thoughts on his experience at the summit. Stay tuned for more updates on ICH E6(R3)!

Feb 2023

openFDA Drug Interaction Visualizer Featured in ACT

By |2023-02-10T13:18:20+02:00February 10, 2023|News|Comments Off on openFDA Drug Interaction Visualizer Featured in ACT

In an interview with Applied Clinical Trials, CEO Artem Andrianov discusses the inspiration behind the tool, its benefits to the industry, and its functionality. The tool is aimed to improve patient outcomes by reducing the risk of negative reactions to combined medications.

Feb 2023

Cyntegrity’s Drug Interaction Visualizer: Finalist for SCOPE Awards

By |2023-02-04T12:39:34+02:00February 4, 2023|Blog, News|Comments Off on Cyntegrity’s Drug Interaction Visualizer: Finalist for SCOPE Awards

We are proud to announce that our Drug Interaction Visualizer has been selected as a finalist for the SCOPE Best of Show Awards. Based on real-world data from the FDA, our visualizer enables clinical research professionals to explore drug interactions and identify potential risks.

Go to Top